Skip to content

Study · Not a test of the peptide alone · 2025

3 results

Multicompartmental Hydrogel Microspheres with a Concentric Thin Oil Layer: Protecting and Targeting Therapeutic Agents for Inflammatory Bowel Disease.

Jeong HS, Choi Y, Kim DW, Je JY, Lee SJ, Choi CH

ACS applied bio materials3 Mar 2025Cited by 3 (Europe PMC)

PMID40030207 (opens in a new tab)DOI10.1021/acsabm.4c01763 (opens in a new tab)PepBankPUB-40030207
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, KPV was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking KPV.

  1. 01LabNot a test of KPV aloneIn vitro (cells)Activity measurement

    Multicompartmental hydrogel microspheres preserved the anti-inflammatory activity of KPV and 5-aminosalicylic acid under stomach conditions.

    In plain wordsIn lab tests, the microspheres kept KPV and 5-ASA active under stomach-like conditions.

    Peptide
    KPV
    Outcome
    Not applicablePreservation of KPV anti-inflammatory activity under stomach conditions
    Study

    n: not reported in source

    Colonic epithelial cells
    Outcome group
    Inflammation markers · Gastrointestinal

    Source sentences

    Summary
    We demonstrate the system's efficacy by preserving the anti-inflammatory activities of 5-aminosalicylic acid (5-ASA) and Lys-Pro-Val (KPV) under stomach conditions and maintaining their therapeutic effects on colonic epithelial cell migration and proliferation.

    In this study, KPV was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking KPV.

  2. 02LabNot a test of KPV aloneIn vitro (cells)Activity measurement

    Microsphere-protected KPV and 5-aminosalicylic acid maintained their therapeutic effect on colonic epithelial cell migration.

    In plain wordsIn lab tests, KPV delivered in the microspheres kept its effect on gut-cell movement.

    Peptide
    KPV
    Outcome
    Not applicableColonic epithelial cell migration with KPV microspheres
    Study

    n: not reported in source

    Colonic epithelial cells
    Outcome group
    Gastrointestinal protection · Gastrointestinal

    Source sentences

    Summary
    We demonstrate the system's efficacy by preserving the anti-inflammatory activities of 5-aminosalicylic acid (5-ASA) and Lys-Pro-Val (KPV) under stomach conditions and maintaining their therapeutic effects on colonic epithelial cell migration and proliferation.

    In this study, KPV was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking KPV.

  3. 03LabNot a test of KPV aloneIn vitro (cells)Activity measurement

    Microsphere-protected KPV and 5-aminosalicylic acid maintained their therapeutic effect on colonic epithelial cell proliferation.

    In plain wordsIn lab tests, KPV delivered in the microspheres kept its effect on gut-cell growth.

    Peptide
    KPV
    Outcome
    Not applicableColonic epithelial cell proliferation with KPV microspheres
    Study

    n: not reported in source

    Colonic epithelial cells
    Outcome group
    Gastrointestinal protection · Gastrointestinal

    Source sentences

    Summary
    We demonstrate the system's efficacy by preserving the anti-inflammatory activities of 5-aminosalicylic acid (5-ASA) and Lys-Pro-Val (KPV) under stomach conditions and maintaining their therapeutic effects on colonic epithelial cell migration and proliferation.

    In this study, KPV was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking KPV.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    9 Oct 2026, 18:17 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 02:56 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.